New CGRP Drug for Cluster Headaches — Approved After Years of Trials

The short answer to the headline is more nuanced than it suggests. As of March 2026, Emgality (galcanezumab), manufactured by Eli Lilly, remains the only...

The short answer to the headline is more nuanced than it suggests. As of March 2026, Emgality (galcanezumab), manufactured by Eli Lilly, remains the only...

Three RSV vaccines are now approved for older adults in the United States, marking a significant shift in how we protect aging populations from a virus...

Remifentanil is the opioid used almost exclusively in hospitals because its potency and ultra-rapid onset make it far too dangerous for outpatient...

Several new autoimmune drugs targeting previously untapped biological pathways have reached approval or late-stage development, and they represent the...

Some patients genuinely do better off certain medications because the side effects, drug interactions, and cognitive burden of treatment can outweigh the...

The antiviral drug in question is acyclovir, originally approved decades ago to treat herpes simplex and varicella-zoster virus — the same virus...

Despite the hopeful framing of this headline, the full picture requires an honest clarification: as of March 2026, no oral drug has yet received FDA...

Therapeutic drug monitoring, often called TDM, is a blood test that measures the concentration of a specific medication in your bloodstream to determine...

Despite headlines suggesting a new atrial fibrillation pill has been approved, the reality is more nuanced — and arguably more interesting.

For decades, men with clinically low testosterone faced a narrow set of options: needles, gels that could rub off on family members, or older oral pills...